Deregulation and Targeting of TP53 Pathway in Multiple MyelomaKatarina Jovanović, Salomon Manier, Paul Chauvet et al.|Frontiers in Oncology|2019Cited by 80
Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptorAadilah Omar, Stefan Weiß, Katarina Jovanović et al.|Expert Opinion on Therapeutic Patents|2010Cited by 35
Prion Interaction with the 37-kDa/67-kDa Laminin Receptor on Enterocytes as a Cellular Model for Intestinal Uptake of PrionsDominika Kolodziejczak, Stefan Weiß, Bertram Brenig et al.|Journal of Molecular Biology|2010Cited by 26